GoodRx Holdings, Inc.
$1.42B- Market cap
- $1.18B
- Debt
- +$500.00M
- Cash
- −$261.82M
Capital structure 70% equity / 30% debt · EV / Revenue 1.78x · EV / EBITDA 7.54x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: GDRX stock price at premium vs JAKK $3.48 current versus $2.57 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at JAKK's multiple
Implied fair value · at GDRX's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Premium justified
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: GDRX FY 2025 (ended Dec 31, 2025) · JAKK FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 70% equity / 30% debt · EV / Revenue 1.78x · EV / EBITDA 7.54x
Capital structure 61% equity / 39% debt · EV / Revenue 0.71x · EV / EBITDA 15.81x
GDRX carries the larger enterprise value at $1.42B against $407.95M; JAKK trades on the lower EV / Revenue multiple (0.71x vs 1.78x); GDRX on the lower EV / EBITDA (7.54x vs 15.81x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
GoodRx Holdings, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
JAKKS Pacific, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.81x
0.72x
Net debt / EBITDA
Leverage against operating earnings
1.26x
4.91x
Cash and equivalents
Liquid reserves on the balance sheet
$261.82M
$52.20M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$500.00M
$178.83M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe GDRX can sustain its positive revenue growth and preserve its stronger EBITDA and ROIC profile, then holding or selectively adding makes sense because the current price is still below the DCF range even though it screens above JAKK-implied P/E value.
GDRX’s current price of $3.05 is above JAKK-implied price of $2.45, implying a -19.6% downside on this framework. However, the stock remains inside its historical band of $2.75 to $3.35 and below the DCF range of $3.44 to $4.65, suggesting the market is not fully pricing in the higher intrinsic-value cases.
Supporting Metrics